ABCL
ABCL
NASDAQ · Life Sciences Tools & Services

Abcellera Biologics Inc

Mid-Cap Stocks Healthcare Stocks
$11.88
+0.75 (+6.74%)
As of Nov 7, 1:55 AM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +277.2% upside
Low Target $32.90
Average Target $44.81
High Target $56.58
Current Price $11.88
Current
$11.88
Target
$44.81
$32.90 $44.81 avg $56.58
Scenario Analysis
Bear Case
$32.90
176.9%
Low target
Base Case
$44.81
+277.2%
Avg target
Bull Case
$56.58
+376.3%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$15.02
-20.9% from high
52-Week Low
$2.75
+332.8% from low
50-Day SMA
$12.28
-3.3% vs SMA
200-Day SMA
$7.04
+68.8% vs SMA
RSI (14)
49.7
Neutral
Target vs 52W High
$44.81
+198.4% vs high
Next Earnings Report
Nov 9, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.18
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 35 86% $369.21 -46.9%
DHR
Danaher Corp
 Strong Buy 31 87% $158.11 -31.3%
A
Agilent Technologies Inc
 Buy 29 72% $64.69 -63.0%
IQV
Iqvia Holdings Inc
 Strong Buy 27 85% $82.96 -69.5%
WAT
Waters Corp
 Buy 30 70% $189.60 -58.6%
MTD
Mettler-Toledo International
 Hold 19 47% $170.43 -90.1%
ILMN
Illumina Inc
 Buy 28 57% $169.36 -20.5%
WST
West Pharmaceutical Services
 Strong Buy 22 95% $136.24 -65.9%